Mesenchymal Stem Cells (MSCs)
The Potential of MSCs
"Stem cell therapies have the potential to do for chronic diseases what antibiotics did for infectious diseases." - Joseph Martin, Former Dean of Harvard Medical
What are MSCs?
Mesenchymal Stem Cells (MSCs) possess the ability to self-renew and generate into differentiated cells. Their regenerative, immunomodulatory, and anti-inflammatory properties have the potential to alleviate many chronic diseases caused by inflammation. Research have shown MSCs help restore old and damaged cells with their tissue-regenerating properties and reduce inflammation by regulating the immune response.
What are the benefits of MSC therapy?
Studies have demonstrated that MSCs reduce inflammation, modulate the immune system, and regenerate damaged or diseased tissue. When used to address chronic diseases whose current treatment methods are insufficient, they may potentially accelerate better health and raise quality of life globally.
What musculoskeletal conditions does MSC therapy address?
Our clinical trials explore the efficacy of MSCs to treat painful joints, cartilage, tendons, ligaments, muscle, and bone. Our hope is to stimulate the body's natural, self-healing mechanisms to decrease pain, improve function, and enable patients to live better and more actively.
Safety
Bone marrow-derived Mesenchymal Stem Cells have been extensively utilized in scientific studies for many years. A meta analysis published in 2021 reviewed 62 randomised clinical trials and concluded that MSC treatment was safe compared to placebo. No serious adverse events were discovered across the included studies.
